SI3221308T1 - Antimikotiki - Google Patents

Antimikotiki

Info

Publication number
SI3221308T1
SI3221308T1 SI201530457T SI201530457T SI3221308T1 SI 3221308 T1 SI3221308 T1 SI 3221308T1 SI 201530457 T SI201530457 T SI 201530457T SI 201530457 T SI201530457 T SI 201530457T SI 3221308 T1 SI3221308 T1 SI 3221308T1
Authority
SI
Slovenia
Prior art keywords
antifungal agents
antifungal
agents
Prior art date
Application number
SI201530457T
Other languages
English (en)
Slovenian (sl)
Inventor
Graham Edward Morris Sibley
Derek Law
Jason David Oliver
Michael Birch
Original Assignee
F2G Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1420743.5A external-priority patent/GB201420743D0/en
Priority claimed from GBGB1505891.0A external-priority patent/GB201505891D0/en
Application filed by F2G Limited filed Critical F2G Limited
Publication of SI3221308T1 publication Critical patent/SI3221308T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01GHORTICULTURE; CULTIVATION OF VEGETABLES, FLOWERS, RICE, FRUIT, VINES, HOPS OR SEAWEED; FORESTRY; WATERING
    • A01G7/00Botany in general
    • A01G7/06Treatment of growing trees or plants, e.g. for preventing decay of wood, for tingeing flowers or wood, for prolonging the life of plants
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/601,4-Diazines; Hydrogenated 1,4-diazines
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002Heterocyclic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Plant Pathology (AREA)
  • Zoology (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Ecology (AREA)
  • Forests & Forestry (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SI201530457T 2014-11-21 2015-11-20 Antimikotiki SI3221308T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB1420743.5A GB201420743D0 (en) 2014-11-21 2014-11-21 Antifungal agents
GBGB1505891.0A GB201505891D0 (en) 2015-04-07 2015-04-07 Antifungal agents
PCT/GB2015/053546 WO2016079536A1 (en) 2014-11-21 2015-11-20 Antifungal agents
EP15800925.8A EP3221308B1 (en) 2014-11-21 2015-11-20 Antifungal agents

Publications (1)

Publication Number Publication Date
SI3221308T1 true SI3221308T1 (sl) 2018-12-31

Family

ID=54704024

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201530457T SI3221308T1 (sl) 2014-11-21 2015-11-20 Antimikotiki

Country Status (20)

Country Link
US (3) US10201524B2 (enExample)
EP (2) EP3415511A1 (enExample)
JP (1) JP6681894B2 (enExample)
KR (1) KR102550341B1 (enExample)
CN (2) CN107207470B (enExample)
AU (1) AU2015348043B2 (enExample)
BR (1) BR112017010439B1 (enExample)
CA (1) CA2982660C (enExample)
CY (1) CY1120907T1 (enExample)
DK (1) DK3221308T3 (enExample)
ES (1) ES2694637T3 (enExample)
HR (1) HRP20182139T1 (enExample)
IL (1) IL252368B (enExample)
LT (1) LT3221308T (enExample)
MX (1) MX2017006447A (enExample)
PL (1) PL3221308T3 (enExample)
PT (1) PT3221308T (enExample)
RU (1) RU2727520C2 (enExample)
SI (1) SI3221308T1 (enExample)
WO (1) WO2016079536A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
US10201524B2 (en) 2014-11-21 2019-02-12 F2G Limited Antifungal agents
US9973887B2 (en) * 2016-01-21 2018-05-15 Google Llc Sharing navigation data among co-located computing devices
CA3015662A1 (en) 2016-03-07 2017-09-14 Agrofresh Inc. Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
GB201609222D0 (en) * 2016-05-25 2016-07-06 F2G Ltd Pharmaceutical formulation
MX2019012116A (es) 2017-04-10 2019-11-21 Scynexis Inc Agentes antifungicos utilizados en combinacion.
AU2018375795A1 (en) 2017-11-30 2020-07-02 Boragen, Inc. Benzoxaborole compounds and formulations thereof
US11236115B2 (en) 2018-08-18 2022-02-01 5Metis, Inc. Solid forms of substituted benzoxaborole and compositions thereof
US11819503B2 (en) 2019-04-23 2023-11-21 F2G Ltd Method of treating coccidioides infection
CN115811989A (zh) 2020-05-29 2023-03-17 法国国家科学研究中心 抗真菌前体药物
CN112358974B (zh) * 2020-12-09 2022-06-10 昆明理工大学 一株植物内生真菌黑附球菌fzt214及其应用
CN116675704A (zh) * 2020-12-21 2023-09-01 深圳市祥根生物医药有限公司 一种吡咯衍生物及其制备方法和用途
CN115109040A (zh) * 2021-03-23 2022-09-27 博瑞生物医药(苏州)股份有限公司 抗真菌化合物,包含其的药物组合物和制剂,及其应用
CN113429396A (zh) * 2021-06-08 2021-09-24 深圳市祥根生物医药有限公司 一种五元杂芳环衍生物及其制备方法和用途
TW202521521A (zh) * 2023-08-08 2025-06-01 大陸商上海森輝醫藥有限公司 一種4-苯基哌啶衍生物及其應用

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3202654A (en) 1962-04-27 1965-08-24 Bristol Myers Co 6-[alpha-hydroxy-and alpha-amino-alpha-pyrrolylacetamido] penicillanic acids and salts thereof
GB1051723A (enExample) 1962-04-27
US3252970A (en) 1963-02-27 1966-05-24 Ciba Geigy Corp Aromatization
BE631632A (enExample) 1963-04-26
US3268558A (en) 1964-11-05 1966-08-23 Ortho Pharma Corp 1-r-2, 4-dinitropyrroles
US3458515A (en) 1966-07-21 1969-07-29 American Home Prod Piperazine substituted pyrroles
GB1208014A (en) 1967-03-23 1970-10-07 Glaxo Lab Ltd Cephalosporins
US3573294A (en) 1968-03-14 1971-03-30 Glaxo Lab Ltd 7 - (arylglyoxamido)cephalosporanic acids and their salts and alpha-carbonyl derivatives
BE790747A (fr) 1971-10-30 1973-02-15 Whitefin Holding Sa Stereo-isomeres du 1-(1'-(0-chloro-benzyl)-pyrrol-2'-yl) -2-dibutyl sec.-amino-ethanol et procede pour leur preparation
GB1476503A (en) 1973-06-21 1977-06-16 Sterling Drug Inc 1-arylamino-and 1-arylimino-pyrroles and preparation thereof
BE848465A (fr) 1976-11-18 1977-03-16 Stereo-isomeres de 1-(1'-benzyl-2' pyrryl)-2-disec.butylaminoethanols a activite analgesique et preparations pharmaceutiques qui les contiennent
US4316900A (en) 1977-10-05 1982-02-23 Ciba-Geigy Corporation Piperazinopyrrolobenzodiazepines
JPS57142966A (en) 1981-02-27 1982-09-03 Sagami Chem Res Center (1-alkyl-2-pyrrolyl)glyoxylic acid amide derivative
JPS57144255A (en) 1981-03-03 1982-09-06 Sagami Chem Res Center Alpha-methylthio(1-alkyl-2-pyrrolyl)acetamide derivative
US4761424A (en) 1985-10-01 1988-08-02 Warner-Lambert Company Enolamides, pharmaceutical compositions and methods for treating inflammation
FR2601368B1 (fr) 1986-07-08 1989-04-07 Synthelabo Derives de nitrofuranne, leur preparation et leur application en therapeutique.
AU650953B2 (en) 1991-03-21 1994-07-07 Novartis Ag Inhaler
US5637592A (en) 1994-07-12 1997-06-10 Janssen Pharmaceutica N.V. Acyl derivatives of azolones
MX9700511A (es) 1994-07-21 1997-04-30 Lilly Co Eli Inhibidores de spla2 de indolizina.
DE69632728T2 (de) 1995-04-28 2004-10-14 Banyu Pharmaceutical Co., Ltd. 1,4-disubstituierte piperidinderivate
DE69517160T2 (de) 1995-06-06 2000-11-16 Agfa-Gevaert N.V., Mortsel Photographische Materialien
JPH09249669A (ja) 1996-03-13 1997-09-22 Ono Pharmaceut Co Ltd 縮合ピロール誘導体、およびそれらを有効成分として含有する薬剤
CN1143679C (zh) * 1997-10-22 2004-03-31 杰恩斯·庞尼阔 治疗和预防粘膜组织炎症的方法和材料
US6331537B1 (en) 1998-06-03 2001-12-18 Gpi Nil Holdings, Inc. Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
CN100351230C (zh) 1998-06-03 2007-11-28 Gpinil控股公司 N-杂环化合物的羧酸和羧酸电子等排物
CZ20013866A3 (cs) 1999-05-04 2002-06-12 Janssen Pharmaceutica N. V. Antifungální ethery
AU6438800A (en) 1999-07-30 2001-02-19 Norbert Heske Cannula system for introducing endoscopic tools in a human or animal body
GB0011089D0 (en) 2000-05-08 2000-06-28 Black James Foundation Gastrin and cholecystokinin receptor ligands (11)
US7202239B2 (en) 2001-04-12 2007-04-10 Wyeth Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists
US6825201B2 (en) 2001-04-25 2004-11-30 Bristol-Myers Squibb Company Indole, azaindole and related heterocyclic amidopiperazine derivatives
ES2266497T3 (es) 2001-06-06 2007-03-01 Vertex Pharmaceuticals Incorporated Inhibidores de cak y usos de los mismos.
CN1826333B (zh) 2001-06-20 2012-12-26 第一三共株式会社 二胺衍生物
TW200306819A (en) 2002-01-25 2003-12-01 Vertex Pharma Indazole compounds useful as protein kinase inhibitors
WO2003072028A2 (en) 2002-02-23 2003-09-04 Bristol-Myers Squibb Company Method of treating hiv infection by preventing interaction of cd4 and gp120
US20050032871A1 (en) 2002-09-03 2005-02-10 Sugen, Inc. Sulfonylated pyrrole-2-indolinone derivatives as kinase inhibitors
WO2004082606A2 (en) 2003-03-13 2004-09-30 Synta Pharmaceuticals Corp. Fused pyrrole compounds
AU2004284084A1 (en) 2003-10-24 2005-05-06 Schering Aktiengesellschaft Indolinone derivatives and their use in treating disease-states such as cancer
US20060058286A1 (en) 2004-09-16 2006-03-16 Mark Krystal Methods of treating HIV infection
US7842810B2 (en) 2005-03-31 2010-11-30 Janssen Pharmaceutica, Nv Bicyclic pyrazole compounds as antibacterial agents
AR053713A1 (es) 2005-04-20 2007-05-16 Xenon Pharmaceuticals Inc Compuestos heterociclicos y sus usos como agentes terapeuticos
EP1888063B1 (en) 2005-05-18 2009-01-14 F2G Ltd. Antifungal agents
US20090176837A1 (en) 2005-07-12 2009-07-09 Sony Corporation Compounds with activity at retinoic acid receptors
WO2007015866A2 (en) 2005-07-20 2007-02-08 Kalypsys, Inc. Inhibitors of p38 kinase and methods of treating inflammatory disorders
US7601844B2 (en) 2006-01-27 2009-10-13 Bristol-Myers Squibb Company Piperidinyl derivatives as modulators of chemokine receptor activity
FR2901144B1 (fr) 2006-05-16 2008-12-26 Diffusion Tech Francaise Sarl Appareils generateur d'aerosols medicaux incluant un dispositif d'amelioration de l'efficacite de depot d'aerosol
WO2008046082A2 (en) 2006-10-12 2008-04-17 Xenon Pharmaceuticals Inc. Use of heterocyclic compounds as therapeutic agents
GB0623209D0 (en) * 2006-11-21 2007-01-03 F2G Ltd Antifungal agents
CN101260086B (zh) 2007-03-06 2011-08-10 中国科学院上海药物研究所 蛋白酪氨酸磷酸酯酶1b抑制剂及其制备方法和用途
GB0710121D0 (en) 2007-05-25 2007-07-04 F2G Ltd Antifungal agents
EP2278957A2 (en) 2008-04-15 2011-02-02 Schering Corporation Oral pharmaceutical compositions in a solid dispersion comprising preferably posaconazole and hpmcas
CA2721944C (en) 2008-04-24 2016-06-07 F2G Ltd Pyrrole antifungal agents
GB0809773D0 (en) 2008-05-29 2008-07-09 F2G Ltd Antifungal combination therapy
WO2010126967A1 (en) 2009-04-28 2010-11-04 Boehringer Ingelheim International Gmbh Ex-vivo treatment of immunological disorders with pkc-theta inhibitors
EP2636409A1 (en) 2010-11-05 2013-09-11 Eisai R&D Management Co., Ltd. Combined pharmaceutical composition as antifungal agent
US10201524B2 (en) 2014-11-21 2019-02-12 F2G Limited Antifungal agents

Also Published As

Publication number Publication date
EP3221308A1 (en) 2017-09-27
US10596150B2 (en) 2020-03-24
ES2694637T3 (es) 2018-12-26
CN107207470B (zh) 2019-12-03
KR102550341B1 (ko) 2023-06-30
PL3221308T3 (pl) 2019-03-29
IL252368B (en) 2020-04-30
US10201524B2 (en) 2019-02-12
DK3221308T3 (en) 2018-12-10
KR20170102241A (ko) 2017-09-08
BR112017010439B1 (pt) 2023-03-07
US20170340607A1 (en) 2017-11-30
CN111096967B (zh) 2023-03-10
RU2017121370A (ru) 2018-12-21
PT3221308T (pt) 2018-12-17
HRP20182139T1 (hr) 2019-05-03
CN107207470A (zh) 2017-09-26
WO2016079536A1 (en) 2016-05-26
JP6681894B2 (ja) 2020-04-15
US20190314333A1 (en) 2019-10-17
EP3415511A1 (en) 2018-12-19
AU2015348043B2 (en) 2019-08-22
IL252368A0 (en) 2017-07-31
LT3221308T (lt) 2018-12-27
CA2982660A1 (en) 2016-05-26
JP2017536371A (ja) 2017-12-07
US20200179340A1 (en) 2020-06-11
MX2017006447A (es) 2018-01-30
AU2015348043A1 (en) 2017-06-08
RU2017121370A3 (enExample) 2019-03-28
CA2982660C (en) 2023-01-24
EP3221308B1 (en) 2018-09-19
US11065228B2 (en) 2021-07-20
RU2727520C2 (ru) 2020-07-22
CN111096967A (zh) 2020-05-05
BR112017010439A2 (pt) 2017-12-26
CY1120907T1 (el) 2019-12-11

Similar Documents

Publication Publication Date Title
ZA201707783B (en) Antifungal compounds
IL252368A0 (en) Antifungal agents
AU361515S (en) Dishrack
AU362944S (en) Lapboard
SG11201608171UA (en) Biocide agents
DK3191586T3 (en) Cellobiosephosphorylase
DK3178931T3 (en) Anti-orai1-antistof
PL3393518T3 (pl) Środek przeciwgrzybiczy
DK3002465T3 (en) Hydrauliksystem
GB201421038D0 (en) Antifungal slipcover
IL249075A0 (en) agent for fluoroalkylation
DK3145380T3 (en) Toiletventilationssystem
PT3096615T (pt) Composição antifúngica
GB201515919D0 (en) Weitwinkelobjektiv
SG11201607674SA (en) Retinoic-acid-producing agent
GB201420743D0 (en) Antifungal agents
GB201505891D0 (en) Antifungal agents
AU5593P (en) Lanmissouri Mandevilla sanderi
AU5594P (en) Lanoregon Mandevilla sanderi
AU5585P (en) Lanutah Mandevilla sanderi
AU5598P (en) Lanidaho Mandevilla sanderi
AU5596P (en) Lannevada Mandevilla sanderi
AU5597P (en) Lancalifornia Mandevilla sanderi
AU5591P (en) Lanmontana Mandevilla sanderi
AU5584P (en) Laniowa Mandevilla sanderi